ArticleBMC cancer2022

Protocol of OGSG 1901: a phase II trial of ramucirumab plus irinotecan for patients with early relapsed gastric cancer during or after adjuvant docetaxel plus S - 1 therapy.

Toshifumi Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.